Duality Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-73,679
| Closed | -$2.28M | – | 60 |
|
|
2024
Q1 | $2.28M | Sell |
73,679
-6,513
| -8% | -$201K | 0.22% | 159 |
|
|
2023
Q4 | $3.24M | Buy |
80,192
+31,036
| +63% | +$1.25M | 0.34% | 87 |
|
|
2023
Q3 | $1.3M | Buy |
+49,156
| New | +$1.3M | 0.16% | 237 |
|
|
2023
Q2 | – | Sell |
-41,972
| Closed | -$696K | – | 521 |
|
|
2023
Q1 | $696K | Buy |
+41,972
| New | +$696K | 0.08% | 360 |
|
|
2022
Q1 | – | Sell |
-216,254
| Closed | -$3.61M | – | 637 |
|
|
2021
Q4 | $3.61M | Buy |
216,254
+180,298
| +501% | +$3.01M | 0.39% | 73 |
|
|
2021
Q3 | $1.69M | Buy |
35,956
+10,174
| +39% | +$477K | 0.13% | 272 |
|
|
2021
Q2 | $1.57M | Buy |
+25,782
| New | +$1.57M | 0.14% | 252 |
|